Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea

Clinical trial NCT06793826 · COMPLETED

Trial details

NCT number: NCT06793826
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatitis B Haemophilus Influenzae Type b Immunisation

Start date: 2025-01-17
Primary completion: 2026-01-15
Enrollment: 713

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.